A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment-Resistant Depression (ENLIGHTEN)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05113771 |
Recruitment Status :
Completed
First Posted : November 9, 2021
Last Update Posted : April 5, 2024
|
Sponsor:
Denovo Biopharma LLC
Information provided by (Responsible Party):
Denovo Biopharma LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 6, 2024 |
Actual Study Completion Date : | March 4, 2024 |